Alnylam Pharmaceuticals (ALNY) Selling, General & Administrative (2009 - 2026)
Alnylam Pharmaceuticals (ALNY) posted Selling, General & Administrative of $347.92 million for Q2 2026, up 7.6% from $323.31 million a year earlier and up 7.9% from the prior quarter.
Powered by 
Analysis
Alnylam Pharmaceuticals (ALNY) Selling, General & Administrative (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Selling, General & Administrative at Alnylam Pharmaceuticals was $1.32 billion, up 22.1% year-over-year; for FY2025, it came in at $1.21 billion, up 24.1% from FY2024.
- Annual Selling, General & Administrative has increased for 12 consecutive years, with a five-year compound annual growth rate of 15.5% (FY2020 to FY2025).
- In prior years, Alnylam Pharmaceuticals' Selling, General & Administrative was $975.53 million in FY2024 (+22.6%), $795.65 million in FY2023 (+3.2%), $770.66 million in FY2022 (+24.2%) and $620.64 million in FY2021 (+5.5%).
- The Q2 2026 figure stands as the highest quarterly Selling, General & Administrative in data going back to Q2 2009.
- On a year-over-year basis, Selling, General & Administrative has increased in each of the last ten quarters, with growth averaging 25.2% over the last eight quarters.
- The strongest year-over-year quarter for Selling, General & Administrative in the past five years was Q3 2022, with growth of 66.0%; the weakest was Q3 2023, with a decline of 15.6%.
- According to Business Quant data, Selling, General & Administrative for the three prior quarters was $322.55 million (Q1 2026), $325.37 million (Q4 2025) and $322.08 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn | 6.43 Bn |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn | 3.63 Bn |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn | 2.90 Bn |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn | -3.24 Bn |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn | -5.65 Bn |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn | 1.75 Bn |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn | 1.92 Bn |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn | 3.41 Bn |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn | 582.20 Mn |
| 10 | Alnylam Pharmaceuticals | 34.23 Bn | 22.28 Bn | 992.69 Mn | 347.92 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 347.92 Mn |
| Mar 31, 2026 | 322.55 Mn |
| Dec 31, 2025 | 325.37 Mn |
| Sep 30, 2025 | 322.08 Mn |
| Jun 30, 2025 | 323.31 Mn |
| Mar 31, 2025 | 239.95 Mn |
| Dec 31, 2024 | 295.34 Mn |
| Sep 30, 2024 | 220.99 Mn |
| Jun 30, 2024 | 248.40 Mn |
| Mar 31, 2024 | 210.80 Mn |
| Dec 31, 2023 | 198.12 Mn |
| Sep 30, 2023 | 199.18 Mn |
| Jun 30, 2023 | 214.69 Mn |
| Mar 31, 2023 | 183.66 Mn |
| Dec 31, 2022 | 210.34 Mn |
| Sep 30, 2022 | 235.86 Mn |
| Jun 30, 2022 | 169.98 Mn |
| Mar 31, 2022 | 154.47 Mn |
| Dec 31, 2021 | 186.38 Mn |
| Sep 30, 2021 | 142.08 Mn |
API Access
Alnylam Pharmaceuticals Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ALNY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "ALNY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ALNY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();